You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 20, 2025

Drug Price Trends for METHADONE HCL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for METHADONE HCL

Average Pharmacy Cost for METHADONE HCL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
METHADONE HCL 10 MG TABLET 00904-6530-61 0.18065 EACH 2025-03-19
METHADONE HCL 10 MG TABLET 00904-7417-61 0.18065 EACH 2025-03-19
METHADONE HCL 10 MG TABLET 00054-0710-20 0.18065 EACH 2025-03-19
METHADONE HCL 10 MG TABLET 00406-5771-62 0.18065 EACH 2025-03-19
METHADONE HCL 5 MG TABLET 67877-0659-01 0.18461 EACH 2025-03-19
METHADONE HCL 10 MG TABLET 00406-5771-01 0.18065 EACH 2025-03-19
METHADONE HCL 10 MG TABLET 00054-0710-25 0.18065 EACH 2025-03-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for METHADONE HCL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
METHADONE HCL 10MG/ML INJ Mylan Institutional LLC 67457-0217-20 20ML 246.15 12.30750 ML 2023-09-29 - 2028-09-28 Big4
METHADONE HCL 10MG/ML INJ Mylan Institutional LLC 67457-0217-20 20ML 246.15 12.30750 ML 2023-09-29 - 2028-09-28 FSS
METHADONE HCL 10MG/ML INJ Mylan Institutional LLC 67457-0217-20 20ML 324.47 16.22350 ML 2023-10-12 - 2028-09-28 FSS
METHADONE HCL 10MG/ML INJ Mylan Institutional LLC 67457-0217-20 20ML 241.10 12.05500 ML 2024-01-01 - 2028-09-28 Big4
METHADONE HCL 10MG/ML INJ Mylan Institutional LLC 67457-0217-20 20ML 324.47 16.22350 ML 2024-01-01 - 2028-09-28 FSS
METHADONE HCL 10MG/ML SOLN,ORAL Golden State Medical Supply, Inc. 66689-0694-30 30ML 66.17 2.20567 ML 2023-06-16 - 2028-06-14 FSS
METHADONE HCL 10MG/ML SOLN,ORAL Golden State Medical Supply, Inc. 66689-0694-79 1000ML 82.22 0.08222 ML 2023-06-16 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Methadone Hydrochloride Market Analysis and Price Projections

Market Overview

Methadone hydrochloride, a synthetic opioid with analgesic properties, is widely used for treating chronic pain, opiate withdrawal, and pain management. Here’s a comprehensive analysis of the methadone hydrochloride market, including its current state, future projections, and key drivers.

Market Size and Growth Projections

The global methadone hydrochloride market has been growing steadily over the past few years. As of 2024, the market size was valued at approximately $67 million[1][4].

  • Forecasted Growth: The market is expected to reach $89 million by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period from 2024 to 2030[1][4].
  • Alternative Forecast: Another projection suggests the market could reach $102.44 million by 2031, also at a CAGR of 4.8%[4].

Key Drivers of the Market

Several factors are driving the growth of the methadone hydrochloride market:

Increasing Prevalence of Chronic Pain

The rising prevalence of chronic pain associated with therapeutic and post-surgical treatments is a significant driver. For instance, according to the U.S. Department of Health & Human Services, in 2016, an estimated 20.4% of U.S. adults had chronic pain, and 8.0% had high-impact chronic pain[5].

Opioid Use Disorder (OUD) Treatment

Methadone hydrochloride is one of the FDA-approved medications for treating Opioid Use Disorder (OUD). The growing need for effective therapeutics in this area contributes to the market growth[3].

New Product Launches

The development and launch of novel methadone hydrochloride products by key companies are expected to drive market growth. For example, the commercial launch of generic methadone hydrochloride tablets by Glenmark Pharmaceuticals has expanded market offerings[5].

Market Segmentation

The methadone hydrochloride market can be segmented in several ways:

By Type

  • Molecular Formula
  • Others[1][4]

By Application

  • Methadone Hydrochloride Tablets
  • Methadone Hydrochloride Oral Solution
  • Other forms[1][4]

By Region

  • North America is expected to hold a dominant position due to the higher prevalence of chronic pain related to cancer and post-surgical pain[5].
  • Europe and the Asia Pacific are also significant regions, with the latter expected to register the strongest CAGR due to increasing awareness and healthcare spending[3].

Price Projections and Current Pricing

Current Pricing

The prices of methadone hydrochloride vary based on the form and dosage:

  • Oral Tablets: The cost for methadone 10 mg oral tablets can range from $19 to $21 for a supply of 100 tablets[2].
  • Oral Solution: Prices range from $21.38 for 150 milliliters to $68.21 for 500 milliliters of the 10 mg/5 mL solution[2].
  • Injectable Solution: The price for 20 milliliters of methadone injectable solution can be around $445.54[2].

Price Trends

Given the forecasted growth, prices are likely to remain stable or see moderate increases, driven by demand and the introduction of new products.

Key Players

The methadone hydrochloride market is dominated by several key players:

  • Roxane Laboratories
  • Mallinckrodt
  • Siegfried Ltd
  • MACFARLAN SMITH
  • Tianjin Central Pharma
  • Eli Lilly and Company
  • Sanofi S.A
  • Hikma Pharmaceuticals PLC[1][4][5].

Challenges and Restraints

Despite the growth, the market faces several challenges:

Regulatory Warnings

The U.S. FDA has issued warnings about the risks associated with methadone, which can reduce its adoption in OUD treatment[3].

Generic Product Influx

The increasing availability of generic methadone hydrochloride products can lead to lower growth rates for branded products[3].

COVID-19 Impact

The COVID-19 pandemic has affected various markets, including the methadone hydrochloride market, through disruptions in supply chains and changes in healthcare priorities[5].

Geographical Insights

North America

This region holds a dominant position due to the high prevalence of chronic pain and opioid use disorder. The U.S. is a key market, with over 1 in 5 adults experiencing chronic pain in 2018[5].

Europe

Europe is expected to hold the second position in the market, driven by new product launches and a rising number of patients suffering from opioid dependency[3].

Asia Pacific

The Asia Pacific region is anticipated to register the strongest CAGR due to increasing awareness and growing healthcare spending[3].

Conclusion

The methadone hydrochloride market is poised for steady growth driven by increasing chronic pain prevalence, the need for OUD treatment, and new product launches. However, it faces challenges such as regulatory warnings and the influx of generic products.

Key Takeaways

  • The global methadone hydrochloride market is expected to grow from $67 million in 2024 to $89 million by 2030 at a CAGR of 4.8%.
  • The market is driven by chronic pain prevalence and the need for OUD treatment.
  • Key players include Roxane Laboratories, Mallinckrodt, and Eli Lilly.
  • North America dominates the market, with the Asia Pacific region expected to show the highest growth.

Frequently Asked Questions

1. What is the projected market size of methadone hydrochloride by 2030?

The global methadone hydrochloride market is projected to reach $89 million by 2030[1].

2. What is the CAGR of the methadone hydrochloride market from 2024 to 2030?

The CAGR is expected to be 4.8% during the forecast period from 2024 to 2030[1].

3. What are the main applications of methadone hydrochloride?

The main applications include methadone hydrochloride tablets, oral solutions, and other forms[1].

4. Which region is expected to dominate the methadone hydrochloride market?

North America is expected to hold a dominant position in the global methadone hydrochloride market[5].

5. Who are the key players in the methadone hydrochloride market?

Key players include Roxane Laboratories, Mallinckrodt, Siegfried Ltd, MACFARLAN SMITH, Tianjin Central Pharma, Eli Lilly and Company, and Sanofi S.A[1][4][5].

Cited Sources

  1. Global Methadone Hydrochloride Market Insights, Forecast to 2030 - Valuates Reports
  2. Methadone Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
  3. Opioid Use Disorder [OUD] Market Size, Share | Growth, 2032 - Fortune Business Insights
  4. Methadone Hydrochloride Market | Global Industry Report, 2031 - Business Research Insights
  5. Methadone Hydrochloride Market - Price, Size, Share & Growth - Coherent Market Insights

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.